Nortech Systems Inc. 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 1999, and the six-month period ended on the same date. Nortech Systems Inc. operates primarily in contract manufacturing for the commercial and defense industries. As of June 30, 1999, the Company decided to discontinue and sell its Display Products and Medical Management segments, classifying them as discontinued operations.
Key Financial Metrics
| Metric | Q2 1999 (3 Months) | Q2 1998 (3 Months) | YTD 1999 (6 Months) | YTD 1998 (6 Months) |
|---|---|---|---|---|
| Revenue (Continuing Ops) | $9,421,813 | $8,374,280 | $18,889,152 | $17,603,629 |
| Gross Profit | $1,634,042 | $1,405,804 | $3,334,181 | $2,855,813 |
| Gross Margin | 17.3% | 16.8% | 17.7% | 16.2% |
| Net Income (Continuing Ops) | $275,744 | $221,468 | $630,542 | $502,173 |
| Net Income (Total) | $(1,159,464) | $187,838 | $(910,757) | $434,270 |
| Cash and Equivalents | $409,956 (as of June 30, 1999) | |||
| Working Capital | $9,539,075 (as of June 30, 1999) | |||
| Total Debt (Current + Long-Term) | $11,413,446 (as of June 30, 1999) |
Material Changes vs. Prior Period
- Revenue Growth: Continuing operations revenue increased 12.5% year-over-year for the quarter and 7.3% for the six-month period, driven by internal growth in contract manufacturing.
- Profitability Shift: While continuing operations generated a net profit of $275,744 for the quarter, the Company reported a total net loss of $1,159,464 due to a $1,180,000 after-tax estimated loss on the sale of discontinued operations.
- Discontinued Operations: The Company recorded a significant impairment and estimated loss on the sale of the Display Products and Medical Management segments. This includes a $1,200,000 reduction in asset value and $600,000 in anticipated closing costs/operating losses.
- Liquidity: Working capital improved to $9,539,075 from $9,080,589 at year-end 1998. Cash flow from operating activities for the six months ended June 30, 1999, was positive at $1,070,401, compared to a use of cash of $924,147 in the prior year period.
Guidance, Outlook, and Risks
- Outlook: Management anticipates revenue levels in the third quarter of 1999 to be approximately the same as the second quarter. The 90-day order backlog was $8,590,000 as of June 30, 1999.
- Disposal Timeline: The Company expects to complete the sale of the discontinued operations in the third quarter of 1999, with interested buyers currently under confidentiality agreements.
- Year 2000 (Y2K) Risk: The Company is nearing completion of the implementation phase of its Y2K Initiative. Testing is nearly complete, with monitoring continuing through 1999 and 2000.
- Liquidity: Management believes operating cash flow and available credit facilities are sufficient to fund expected growth.
Investor Verification Checklist
- Verify the final sale price and closing date of the Display Products and Medical Management segments to confirm the accuracy of the $1,180,000 estimated loss.
- Monitor the sustainability of the 17.7% gross margin in the contract manufacturing segment as the company transitions to a single-segment operation.
- Review the status of the $11.4 million total debt obligations and the company's ability to service this debt without the cash flow from discontinued operations.
- Confirm the completion of Y2K testing and any potential operational disruptions in the transition to the year 2000.